Retatrutide vs Tirzepatide: A Research Comparison
Retatrutide and tirzepatide share two receptors; retatrutide adds a third. Here is a clear research comparison of the dual versus triple agonist.
Retatrutide and tirzepatide are closely related in metabolic research because they share two of the same receptor targets. The distinction is a single additional receptor: tirzepatide is a dual agonist, while retatrutide is a triple agonist. That one extra pathway is the core of how researchers tell them apart.
Tirzepatide — a dual GIP/GLP-1 agonist
Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Preclinical research describes modulation of glycemic signaling and adipose-tissue regulation, characterizing how the two incretin pathways act together rather than separately.
Retatrutide — a triple agonist
Retatrutide targets the same GIP and GLP-1 receptors as tirzepatide, then adds a third: the glucagon receptor. That glucagon pathway is associated in preclinical literature with energy expenditure and hepatic lipid handling. Research describes differential receptor activation profiles for retatrutide, meaning the relative potency across all three receptors — not just the count — is part of what is characterized.
The core difference: the glucagon receptor
Because the two share the GIP and GLP-1 receptors, the glucagon receptor is the single variable that separates them. Studies comparing the two examine what that third pathway adds on top of the dual-incretin baseline that tirzepatide already provides. Semaglutide sits one step below tirzepatide as a single GLP-1 agonist; our three-way comparison covers the full one-to-three progression.
Side-by-side summary
- Tirzepatide — 2 receptors: GIP + GLP-1
- Retatrutide — 3 receptors: GIP + GLP-1 + glucagon
- They share the two incretin receptors; the glucagon receptor is the difference
- The added glucagon pathway is studied in preclinical work on energy expenditure and hepatic lipid handling
Laboratory handling notes
- Both are supplied as lyophilized powder; allow the sealed vial to reach room temperature before opening
- Reconstitute gently with an appropriate solvent rather than shaking
- Store reconstituted solution cold and aliquot to avoid repeated freeze-thaw cycles
- Confirm the batch lot on your vial matches the accompanying Certificate of Analysis
Both compounds are supplied for research use only, third-party tested to 98%+ purity by HPLC with a COA included. Retatrutide is currently in stock; use the restock alerts on each product page to be notified when a size returns.
This article is provided for laboratory and in-vitro research context only. Pulse Peptide Labs products are not for human consumption, diagnostic, therapeutic, or medical use, and nothing here is medical advice.
Keep reading
Research-grade peptides, COA included
Every batch is third-party tested for purity and identity. Browse the catalog.
Browse Products